search
Back to results

Medtronic Closed-Loop Spinal Cord Stimulation System

Primary Purpose

Low Back Pain, Leg Pain, Upper Limb Pain

Status
Active
Phase
Not Applicable
Locations
Australia
Study Type
Interventional
Intervention
Inceptiv
Sponsored by
MedtronicNeuro
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Low Back Pain

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 18 years of age or older
  • Candidate is undergoing Medtronic SCS device trial for chronic, intractable pain of the trunk and/or limbs
  • If being treated for low-back and/or leg pain,

    • the baseline overall^ Visual Analog Scale is ≥ 60 mm and
    • baseline back and/or leg pain Visual Analog Scale is ≥60 mm. ^Average overall pain in the back and/or leg in the 72 hours prior to the baseline visit, measured using Visual Analog Scale.
  • If being treated for upper limb pain - baseline Visual Analog Scale is ≥ 60 mm for upper limb pain
  • On stable (no change in dose, route, or frequency) prescribed pain medications being used for back and leg pain or upper limb pain, as determined by the investigator, for at least 28 days prior to device trial
  • Willing and able to provide signed and dated informed consent
  • Willing and able to comply with all study procedures and visits

Exclusion Criteria:

  • Indicated for an SCS device to treat stable intractable Angina Pectoris or Peripheral Vascular Disease of Fontaine Stage III or higher
  • Previously trialed or implanted with spinal cord stimulator, peripheral or vagus nerve stimulator, deep brain stimulator or an implantable intrathecal drug delivery system
  • Currently participating, or plans to participate, in another investigational study unless written approval is provided by the Medtronic study team
  • Major psychiatric comorbidity or other progressive diseases that may confound study results, as determined by the Investigator
  • Serious drug-related behavioral issues (e.g. alcohol dependency, illegal substance abuse), as determined by the Investigator
  • Pregnant or planning on becoming pregnant (if female and sexually active, subject must be using a reliable form of birth control, be surgically sterile, or be at least 2 years post-menopausal)
  • Be involved in an injury claim or under current litigation

Sites / Locations

  • Sydney Pain Specialists
  • Genesis Research Services
  • Australian Medical Research
  • Royal North Shore Hospital
  • Sydney Pain Research Centre
  • Sunshine Coast Clinical Research
  • Precision Brain Spine and Pain Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Treatment

Arm Description

Outcomes

Primary Outcome Measures

Reduction in overstimulation sensation
Comparison of Neuro Sense On vs Off at in-clinic testing for low-back and/or leg pain subjects. Subjects will perform protocol prescribed activities and rate the intensity of the sensation on a 5-point Likert scale. The average intensity scores during each period will be calculated for each subject. The proportion of low-back and leg pain subjects with a reduction in overstimulation sensation during Neuro Sense On compared to Neuro Sense Off will be calculated, with a one-sided 97.5% lower bound.

Secondary Outcome Measures

Responder rate for treatment of overall pain
Low-back and/or leg pain subjects
Responder rate for treatment of low-back pain
Low-back pain subjects (baseline back VAS ≥60mm)
Responder rate for treatment of leg pain
Leg pain subjects (baseline leg VAS ≥60mm)

Full Information

First Posted
November 30, 2021
Last Updated
June 6, 2023
Sponsor
MedtronicNeuro
search

1. Study Identification

Unique Protocol Identification Number
NCT05177354
Brief Title
Medtronic Closed-Loop Spinal Cord Stimulation System
Official Title
Evaluation of Long-term Patient Experience With a Medtronic Closed-Loop Spinal Cord Stimulation System
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
November 30, 2021 (Actual)
Primary Completion Date
May 4, 2023 (Actual)
Study Completion Date
August 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
MedtronicNeuro

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the study is to further understand the closed-loop feature in chronically implanted patients by characterizing the efficacy of the next generation, spinal cord stimulator.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Low Back Pain, Leg Pain, Upper Limb Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
94 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Treatment
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Inceptiv
Intervention Description
Implantable Neurostimulator with Neuro Sense
Primary Outcome Measure Information:
Title
Reduction in overstimulation sensation
Description
Comparison of Neuro Sense On vs Off at in-clinic testing for low-back and/or leg pain subjects. Subjects will perform protocol prescribed activities and rate the intensity of the sensation on a 5-point Likert scale. The average intensity scores during each period will be calculated for each subject. The proportion of low-back and leg pain subjects with a reduction in overstimulation sensation during Neuro Sense On compared to Neuro Sense Off will be calculated, with a one-sided 97.5% lower bound.
Time Frame
30 days from device activation
Secondary Outcome Measure Information:
Title
Responder rate for treatment of overall pain
Description
Low-back and/or leg pain subjects
Time Frame
3 months from device activation
Title
Responder rate for treatment of low-back pain
Description
Low-back pain subjects (baseline back VAS ≥60mm)
Time Frame
3 months from device activation
Title
Responder rate for treatment of leg pain
Description
Leg pain subjects (baseline leg VAS ≥60mm)
Time Frame
3 months from device activation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18 years of age or older Candidate is undergoing Medtronic SCS device trial for chronic, intractable pain of the trunk and/or limbs If being treated for low-back and/or leg pain, the baseline overall^ Visual Analog Scale is ≥ 60 mm and baseline back and/or leg pain Visual Analog Scale is ≥60 mm. ^Average overall pain in the back and/or leg in the 72 hours prior to the baseline visit, measured using Visual Analog Scale. If being treated for upper limb pain - baseline Visual Analog Scale is ≥ 60 mm for upper limb pain On stable (no change in dose, route, or frequency) prescribed pain medications being used for back and leg pain or upper limb pain, as determined by the investigator, for at least 28 days prior to device trial Willing and able to provide signed and dated informed consent Willing and able to comply with all study procedures and visits Exclusion Criteria: Indicated for an SCS device to treat stable intractable Angina Pectoris or Peripheral Vascular Disease of Fontaine Stage III or higher Previously trialed or implanted with spinal cord stimulator, peripheral or vagus nerve stimulator, deep brain stimulator or an implantable intrathecal drug delivery system Currently participating, or plans to participate, in another investigational study unless written approval is provided by the Medtronic study team Major psychiatric comorbidity or other progressive diseases that may confound study results, as determined by the Investigator Serious drug-related behavioral issues (e.g. alcohol dependency, illegal substance abuse), as determined by the Investigator Pregnant or planning on becoming pregnant (if female and sexually active, subject must be using a reliable form of birth control, be surgically sterile, or be at least 2 years post-menopausal) Be involved in an injury claim or under current litigation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marc Russo, MD
Organizational Affiliation
Genesis Research Services
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sydney Pain Specialists
City
Bella Vista
State/Province
New South Wales
ZIP/Postal Code
2153
Country
Australia
Facility Name
Genesis Research Services
City
Broadmeadow
State/Province
New South Wales
ZIP/Postal Code
2292
Country
Australia
Facility Name
Australian Medical Research
City
Hurstville
State/Province
New South Wales
ZIP/Postal Code
2220
Country
Australia
Facility Name
Royal North Shore Hospital
City
Saint Leonards
State/Province
New South Wales
ZIP/Postal Code
2065
Country
Australia
Facility Name
Sydney Pain Research Centre
City
Wahroonga
State/Province
New South Wales
ZIP/Postal Code
2076
Country
Australia
Facility Name
Sunshine Coast Clinical Research
City
Noosa Heads
State/Province
Queensland
ZIP/Postal Code
4567
Country
Australia
Facility Name
Precision Brain Spine and Pain Center
City
Kew
State/Province
Victoria
ZIP/Postal Code
3101
Country
Australia

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Medtronic Closed-Loop Spinal Cord Stimulation System

We'll reach out to this number within 24 hrs